FindTrial
Sign In

Perioperative outcome of Covid-19 associated Mucormycosis

Perioperative outcome of COVID-19 Associated Rhino-Occulo-Cerebral Mucormycosis: An observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/034665
Enrollment
50
Registered
2021-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B465- Mucormycosis, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

All India Institute of Medical Sciences Raipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: COVID-19 Associated Mucormycosis (CAM) Adults Both elective and Emergency

Exclusion criteria

Exclusion criteria: Non-COVID-19 Associated Mucormycosis American Society of Anaesthesiologists physical class VI

Design outcomes

Primary

MeasureTime frame
All Cause Morbidity and MortalityTimepoint: At baseline, day 2 postop—

Secondary

MeasureTime frame
Length of stay in Intensive Care unityTimepoint: day 28—

Countries

India

Contacts

Public ContactDr Habib Md Reazaul Karim

All India Institute of Medical Sciences Raipur

drhabibkarim@gmail.com9612372585

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026